Bon Natural Life Ltd Files July 2025 6-K Report

Ticker: BON · Form: 6-K · Filed: Jul 21, 2025 · CIK: 1816815

Sentiment: neutral

Topics: reporting, 6-K, foreign-private-issuer

TL;DR

Bon Natural Life (BNL) filed its July 6-K, confirming its reporting status as a foreign private issuer.

AI Summary

Bon Natural Life Limited filed a Form 6-K on July 21, 2025, for the month of July 2025. The company, incorporated in E9 with a fiscal year end of September 30, is a foreign private issuer and files annual reports under Form 20-F. Its principal executive offices are located in Xi'an, Shaanxi, China.

Why It Matters

This filing indicates ongoing reporting compliance for Bon Natural Life Ltd, a company in the medicinal chemicals and botanical products sector.

Risk Assessment

Risk Level: low — This is a routine periodic filing with no new material financial or operational information disclosed.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, for the month of July 2025.

What is Bon Natural Life Limited's SEC File Number?

Bon Natural Life Limited's SEC File Number is 001-40517.

Where are Bon Natural Life Limited's principal executive offices located?

Bon Natural Life Limited's principal executive offices are located at Room 601, Block C, Gazelle Valley, No.69, Jinye Road High-Tech Zone, Xi'an, Shaanxi, China.

Does Bon Natural Life Limited file its annual reports under Form 20-F or Form 40-F?

Bon Natural Life Limited files its annual reports under cover of Form 20-F.

What is the SIC code for Bon Natural Life Ltd?

The Standard Industrial Classification (SIC) code for Bon Natural Life Ltd is 2833, which corresponds to MEDICINAL CHEMICALS & BOTANICAL PRODUCTS.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on July 21, 2025 regarding Bon Natural Life Ltd (BON).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing